» Articles » PMID: 37915380

Biallelic Pathogenic Variants in Alter TRNA Transcription and Cause a Hypomyelinating Leukodystrophy: A Case Report

Overview
Journal Front Neurol
Specialty Neurology
Date 2023 Nov 2
PMID 37915380
Authors
Affiliations
Soon will be listed here.
Abstract

RNA polymerase III-related leukodystrophy (POLR3-related leukodystrophy) is a rare, genetically determined hypomyelinating disease arising from biallelic pathogenic variants in genes encoding subunits of RNA polymerase III (Pol III). Here, we describe the first reported case of POLR3-related leukodystrophy caused by biallelic pathogenic variants in , encoding the RPC4 subunit of Pol III. The individual, a female, demonstrated delays in walking and expressive and receptive language as a child and later cognitively plateaued. Additional neurological features included cerebellar signs (e.g., dysarthria, ataxia, and intention tremor) and dysphagia, while non-neurological features included hypodontia, hypogonadotropic hypogonadism, and dysmorphic facial features. Her MRI was notable for diffuse hypomyelination with myelin preservation of early myelinating structures, characteristic of POLR3-related leukodystrophy. Exome sequencing revealed the biallelic variants in , a missense variant (c.541C > T, p.P181S) and an intronic splice site variant (c.656-6G > A, p.?). Functional studies of the patient's fibroblasts demonstrated significantly decreased RNA-level expression of , along with reduced expression of other Pol III subunit genes. Notably, Pol III transcription was also shown to be aberrant, with a significant decrease in RNA and several distinct tRNA genes analyzed. Affinity purification coupled to mass spectrometry of the p.P181S variant showed normal assembly of Pol III subunits yet altered interaction of Pol III with the PAQosome chaperone complex, indicating the missense variant is likely to alter complex maturation. This work identifies biallelic pathogenic variants in as a novel genetic cause of POLR3-related leukodystrophy, expanding the molecular spectrum associated with this disease, and proposes altered tRNA homeostasis as a factor in the underlying biology of this hypomyelinating disorder.

Citing Articles

Tremor Ataxia With Central Hypomyelation Phenotype Related to a Recurrent POLR3A Mutation in Six Unrelated Tunisian Families.

Kraoua I, Jamoussi M, Drissi C, Kraoua L, Drunat S, Benrhouma H Mol Genet Genomic Med. 2024; 12(10):e70007.

PMID: 39436788 PMC: 11495397. DOI: 10.1002/mgg3.70007.


Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study.

Lentini L, Toutounchi H, Chapleau A, Le A, Fournier S, Emari F J Child Neurol. 2024; 40(1):26-38.

PMID: 39429022 PMC: 11590388. DOI: 10.1177/08830738241283171.


Towards a Treatment for Leukodystrophy Using Cell-Based Interception and Precision Medicine.

Coulombe B, Chapleau A, Macintosh J, Durcan T, Poitras C, Moursli Y Biomolecules. 2024; 14(7).

PMID: 39062571 PMC: 11274857. DOI: 10.3390/biom14070857.


The 37TrillionCells initiative for improving global healthcare via cell-based interception and precision medicine: focus on neurodegenerative diseases.

Coulombe B, Durcan T, Bernard G, Moursli A, Poitras C, Faubert D Mol Brain. 2024; 17(1):18.

PMID: 38605409 PMC: 11007934. DOI: 10.1186/s13041-024-01088-4.

References
1.
Soden S, Saunders C, Willig L, Farrow E, Smith L, Petrikin J . Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med. 2014; 6(265):265ra168. PMC: 4286868. DOI: 10.1126/scitranslmed.3010076. View

2.
Dorboz I, Dumay-Odelot H, Boussaid K, Bouyacoub Y, Barreau P, Samaan S . Mutation in causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation. Neurol Genet. 2018; 4(6):e289. PMC: 6283457. DOI: 10.1212/NXG.0000000000000289. View

3.
Timmons M, Tsokos M, Asab M, Seminara S, Zirzow G, Kaneski C . Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia. Neurology. 2006; 67(11):2066-9. PMC: 1950601. DOI: 10.1212/01.wnl.0000247666.28904.35. View

4.
Worth P, Houlden H, Giunti P, Davis M, Wood N . Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat Genet. 2000; 24(3):214-5. DOI: 10.1038/73411. View

5.
Watt K, Macintosh J, Bernard G, Trainor P . RNA Polymerases I and III in development and disease. Semin Cell Dev Biol. 2022; 136:49-63. PMC: 9550887. DOI: 10.1016/j.semcdb.2022.03.027. View